Advertisement

Topics

Living Cell Technologies Limited Company Profile

18:35 EST 20th November 2018 | BioPortfolio

Living Cell Technologies (LCT) is an Australasian biotechnology company improving the wellbeing of people with serious diseases worldwide by discovering, developing and commercializing regenerative treatments that restore function using naturally occurring cells. LCT’s unique proprietary encapsulation delivery technology, IMMUPEL™, coats cells with protective capsules that prevent them from attack by the immune system. This allows cell therapies to be used without the need for immunosuppressive drugs. LCT’s lead product, NTCELL®, is being developed for neurodegenerative diseases. LCT recently completed a Phase I/IIa clinical trial of NTCELL in New Zealand for the treatment of Parkinson’s disease and plans to initiate a Phase IIb study in the fourth quarter of 2015. LCT holds a 50 percent interest in Diatranz Otsuka Limited, which is developing DIABECELL®, a cell therapy in late-stage clinical trials for the treatment of type 1 diabetes. LCT is listed on the Australian (ASX: LCT) and United States (OTCQX: LVCLY) stock exchanges. The company is incorporated in Australia, with research and development and operations based in New Zealand. For more information, visit www.lctglobal.com or follow @lctglobal on Twitter.


News Articles [1969 Associated News Articles listed on BioPortfolio]

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims ...

An Introduction to Live Cell Imaging

The term live cell imaging collectively refers to the technologies used to capture images of cells in a living, active state, either as individual static pictures or as time-lapse series. Correspondin...

Pig Cell Potential, PTV News: Feb 15, 2010

A revolutionary treatment for type 1 diabetes. We interview Paul Tan, the CEO of Living Cell Technologies.[Feb 15, 16:10 GMT]

Implant Trials, PTV News: May 12, 2010

Living Cell Technologies CEO discusses Phase II Trials of pig cell implant treatment

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

Artificial Intelligence Takes Scientists Inside Living Human Cells

(NPR) – A new application of artificial intelligence could help researchers solve medical mysteries ranging from cancer to Alzheimer’s. It’s a 3D model of a living human cell that le...

Allen integrated cell released online

(Allen Institute) The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell. By allowing researchers around t...

Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China

MELBOURNE, Australia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Representatives of the Hainan Government - Hainan Ecological Smart City Group (“HESCG”), a Chinese industrial park development & oper...

PubMed Articles [3914 Associated PubMed Articles listed on BioPortfolio]

What do we know about technologies for dementia-related wandering? A scoping review: Examen de la portée : Que savons-nous à propos des technologies de gestion de l'errance liée à la démence?

Occupational therapists use technologies to manage wandering-related risks to promote safety and independence among individuals with dementia living in the community.

Integrative analysis of single-cell expression data reveals distinct regulatory states in bidirectional promoters.

Bidirectional promoters (BPs) are prevalent in eukaryotic genomes. However, it is poorly understood how the cell integrates different epigenomic information, such as transcription factor (TF) binding ...

A First Glimpse of Nucleation of Phase Transitions in Living Cells.

Prion formation and propagation involve the nucleation and growth of protein-based supramolecular assemblies. In this issue of Molecular Cell, Khan et al. (2018) report novel methods that enable quan...

Challenges for successful implantation of biofuel cells.

There is a growing interest in the design and engineering of operational biofuel cells that can be implanted. This review highlights the recent progress in the electrochemistry of biofuel cell technol...

Genome editing in the mammalian brain using the CRISPR-Cas system.

Recent advances in genome editing technologies such as the clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonuclease Cas9 have enabled the rapid and efficient modifica...

Clinical Trials [8145 Associated Clinical Trials listed on BioPortfolio]

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)

This study will validate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity in...

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma

This study investigate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity inde...

Living Alone in Old Age With Cognitive Impairment

The purpose of this study is to better understand the experience of living alone in older age with cognitive impairment. We recruit adults 55+ living alone with cognitive impairment such ...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Companies [2849 Associated Companies listed on BioPortfolio]

Chip-Man Technologies Ltd

Chip-man Technolgies was formed in 2002 from researchers from the University of Tampere, Technical University of Tampere and the Finnish Research Organisation, VTT. The founders combined expertise to ...

Living Cell Technologies Limited

Living Cell Technologies (LCT) is an Australasian biotechnology company improving the wellbeing of people with serious diseases worldwide by discovering, developing and commercial...

Anima Cell Metrology, Inc

Anima Cell Metrology, Inc is a privately owned, US based company developing novel technologies to monitor protein synthesis in living cells. The company is generating and commerci...

Atto Bioscience

Atto Bioscience is changing the way cell analysis is done. With systems that allow real-time kinetic imaging of individual cells within a population, Atto Bioscience provides integrated solutions for ...

Five Star Senior Living Inc.

Five Star Senior Living Inc. is a senior living and healthcare services company. As of December 31, 2016, Five Star operated 283 senior living communities with 31,830 living un...

More Information about "Living Cell Technologies Limited" on BioPortfolio

We have published hundreds of Living Cell Technologies Limited news stories on BioPortfolio along with dozens of Living Cell Technologies Limited Clinical Trials and PubMed Articles about Living Cell Technologies Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Living Cell Technologies Limited Companies in our database. You can also find out about relevant Living Cell Technologies Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record